Related Experiment Videos
Is Burkitt's lymphoma related to perinatal infection by Epstein-Barr virus?
Insights
Neonatal Epstein-Barr virus (E.B.V.) infection is a significant risk factor for Burkitt's lymphoma (B.L.). This finding emerged from comparing E.B.V. epidemiological data globally, suggesting a parallel with animal tumor viruses.
Area of Science:
- Oncology
- Virology
- Epidemiology
Background:
- Burkitt's lymphoma (B.L.) exhibits a distinct geographical distribution.
- Epstein-Barr virus (E.B.V.) is globally prevalent and a suspected causal agent for B.L.
Purpose of the Study:
- To investigate the hypothesis that perinatal E.B.V. infection is a risk factor for B.L.
- To explore the epidemiological characteristics of E.B.V. infection in relation to B.L. incidence.
Main Methods:
- Comparative analysis of E.B.V. epidemiological data worldwide.
- Preliminary results from a prospective seroepidemiological study of B.L.
Main Results:
- E.B.V. infection patterns vary globally, correlating with B.L. distribution.
- Prospective study data preliminarily supports the perinatal infection hypothesis.
Conclusions:
- Neonatal E.B.V. infection is proposed as a key risk factor for B.L. development.
- E.B.V.'s oncogenic potential may be significantly amplified by neonatal infection, similar to animal tumor viruses.
Abstract:
Burkitt's lymphoma (B.L.) is very restricted geographically, whereas the Epstein-Barr virus (E.B.V.), a very likely causal factor, exists all over the world. It is proposed that perinatal infection (either transplacental, or, more probably, neonatal) is an important risk factor for the development of B.L. This hypothesis arose when the epidemiological characteristics of E.B.V. infection were compared in different parts of the world and is supported by the preliminary results of a seroepidemiological prospective study of B.L. E.B.V. would behave in a manner similar to that of animal tumour viruses whose oncogenic potential is greatly enhanced by neonatal infection.